← Back to Analyst Consensus 
TRVI Buy
Trevi Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Aug 7, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Aug 7, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Jul 21, 2026 | BMO Capital | initiate | Outperform → Outperform | — | 53% |
| Jul 20, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Jul 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 20, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 6, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 17, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 19, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Mar 18, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 18, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 18, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 9, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jan 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $21 | 44% |
| Jan 8, 2026 | D. Boral Capital | maintain | Buy → Buy | $19 | 34% |
| Dec 19, 2025 | Stifel | maintain | Buy → Buy | $18 | 53% |
| Nov 20, 2025 | Leerink Partners | maintain | Outperform → Outperform | $16 | 50% |
| Nov 14, 2025 | D. Boral Capital | maintain | Buy → Buy | $19 | 34% |
| Nov 14, 2025 | Oppenheimer | maintain | Outperform → Outperform | $24 | 52% |
| Nov 14, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $19 | 54% |
| Nov 14, 2025 | Clear Street | maintain | Buy → Buy | $21 | 48% |
| Aug 21, 2025 | Morgan Stanley | initiate | — → Overweight | $18 | 54% |
| Aug 8, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $27 | 54% |
| Aug 8, 2025 | Needham | maintain | Buy → Buy | $22 | 50% |
| Jul 1, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $25 | 50% |
| Jun 2, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| May 28, 2025 | HC Wainwright & Co. | initiate | — → Buy | $21 | 44% |
| May 20, 2025 | Needham | reiterate | Buy → Buy | $24 | 50% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $24 | 50% |
| Mar 19, 2025 | B. Riley Securities | reiterate | Buy → Buy | $20 | 54% |
| Mar 19, 2025 | Needham | maintain | Buy → Buy | $24 | 50% |
| Mar 19, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Mar 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12.5 | 44% |
| Mar 11, 2025 | Oppenheimer | maintain | Outperform → Outperform | $20 | 52% |
| Mar 10, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12.5 | 44% |
| Mar 10, 2025 | Raymond James | upgrade | Outperform → Strong Buy | $29 | 54% |
| Mar 10, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Mar 10, 2025 | Needham | maintain | Buy → Buy | $25 | 50% |
| Mar 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Feb 24, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Jan 8, 2025 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Dec 16, 2024 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Dec 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7.5 | 44% |
| Dec 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7.5 | 44% |
| Dec 12, 2024 | D. Boral Capital | maintain | Buy → Buy | $21 | 34% |
| Dec 12, 2024 | Needham | reiterate | Buy → Buy | $8 | 50% |
| Dec 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $0 | 44% |
Price Target Trend
Apr 17, 2026 Latest: $28.18 Oct 24, 2026
EPS Estimates
0y $-0.48
Lo: $-0.58 Hi: $-0.34
10 analysts ▲2
0q $-0.13
Lo: $-0.18 Hi: $-0.11
10 analysts +1y $-0.58
Lo: $-0.76 Hi: $-0.40
10 analysts ▲1
+1q $-0.14
Lo: $-0.20 Hi: $-0.07
10 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days